ANXA1 and colorectal cancer: MDX-124 caused a significant reduction in cellular proliferation in all breast, pancreatic, ovarian and colorectal cancer cell lines expressing ANXA1 when compared to an IgG1 isotype control antibody (Fig. 1, p < 0.05).